查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608148

子宫内避孕器市场：按类型、年龄层、最终用户划分 - 全球预测 2025-2030

Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年子宫内避孕器市场价值为31.3亿美元，预计到2024年将达到32.4亿美元，复合年增长率为4.59%，到2030年将达到42.9亿美元。

子宫内避孕器器(IUD) 是长期避孕解决方案的重要组成部分。子宫内避孕器是一种小型 T 型避孕器，可插入子宫以防止怀孕，提供安全且可逆的选择。这种需求源自于对计划生育和生殖健康管理的日益重视。子宫内避孕器不仅用于避孕，也常用于治疗月经疼痛等月经失调。主要最终用户是已开发国家和开发中国家寻求有效避孕解决方案的妇女。市场成长受到多种因素的推动，例如性健康意识的提高、政府控制人口的努力以及医疗基础设施的改善以促进性健康。在传统上避孕器具使用率较低的农村地区，以及可以获得咨询和子宫内避孕器资讯的数位推广保健平台上，存在着大量的机会。诸如具有延长保质期的子宫内避孕器和荷尔蒙平衡等其他健康益处的技术进步也提供了一条充满希望​​的前进道路。然而，存在一些限制可能会阻止某些人群，例如对副作用的误解、某些地区的文化障碍以及植入的初始成本。市场挑战包括潜在的併发症，例如插入后感染疾病以及医疗系统不太健全的欠发达地区的准入有限。创新研发领域包括开发经济高效、生物分解性的子宫内避孕器和智慧设备，使医疗保健专业人员能够远端监测患者健康状况。我们业务成长的驱动力是加强与医疗机构的伙伴关係以及促进教育和意识计划。子宫内避孕器市场在高度创新和文化犹豫之间摇摆不定，巨大的机会在于解开子宫内避孕器被误解的方面，并将其整合到更广泛的医疗保健计划中。对个人化医疗和生物技术进步的热切关注有可能重新定义产品供应、满足多样化的消费者需求并推动市场的显着扩张。

主要市场统计
基准年[2023] 31.3亿美元
预计年份 [2024] 32.4亿美元
预测年份 [2030] 42.9亿美元
复合年增长率（%） 4.59%

市场动态：快速发展的子宫内避孕器市场的关键市场洞察

避孕器内避孕器市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 避免意外怀孕的做法越来越受欢迎
    • 政府和非政府组织努力普及子宫内避孕器
  • 市场限制因素
    • 使用子宫内避孕器时担心带子流失和感染风险
  • 市场机会
    • 专注于设计下一代 IUD（子宫内避孕器）
    • 智慧型子宫内避孕器的出现
  • 市场挑战
    • 居民的认识与传播有限

波特五力：驾驭子宫内避孕器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解子宫内避孕器市场的外在影响

外部宏观环境因素对子宫内避孕器市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解子宫内避孕器市场的竞争状况

对避孕器内避孕器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵避孕器市场供应商的绩效评估

FPNV定位矩阵是评估子宫内避孕器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘子宫内避孕器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对子宫内避孕器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加收养以避免意外怀孕
      • 政府和非政府组织努力推广子宫内避孕器
    • 抑制因素
      • 使用子宫内避孕器时担心线脱落和感染风险
    • 机会
      • 专注于设计下一代 IUD（子宫内避孕器）
      • 推出智慧型子宫内避孕器
    • 任务
      • 大众的认识和采纳有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章子宫内避孕器市场：依类型

  • 荷尔蒙：释放黄体素的子宫内避孕器
  • 非荷尔蒙：含铜子宫内避孕器

第七章子宫内避孕器市场：依年龄组别

  • 15-24岁
  • 25-34岁
  • 35-44岁
  • 44岁以上

第八章子宫内避孕器市场：依最终用户分类

  • 诊所
  • 社区健康服务中心
  • 医院

第九章 北美及南美子宫内避孕器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太宫内避孕器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲子宫内避孕器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Actavis Generics by Teva Pharmaceutical Industries Ltd.
  • Agile Therapeutics, Inc.
  • Allergan Plc by Abbvie Inc
  • Ava AG
  • Bayer AG
  • Cardinal Health, Inc.
  • Contrel Europe NV
  • CooperSurgical Inc.
  • Egemen International
  • ERENLER MEDIKAL SAN. TIC. LTD. STI.
  • Eurogine SL
  • Fuji Latex Co., Ltd.
  • HLL Lifecare Limited
  • HRA Pharma, SAS
  • Melbea AG
  • Merck & Co., Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Mona Lisa NV
  • Mylan NV by Viatris Inc.
  • Novartis AG
  • Ocon Medical Ltd
  • Pregna International Limited
  • Prosan International BV
  • Searchlight Pharma Inc.
  • SMB Corporation of India
Product Code: MRR-8E22B61932AA

The Intrauterine Devices Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.24 billion in 2024, and is projected to grow at a CAGR of 4.59%, to USD 4.29 billion by 2030.

Intrauterine devices (IUDs) represent a crucial segment of long-term contraceptive solutions. They are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy, offering a safe and reversible option. Their necessity stems from the growing emphasis on family planning and control over reproductive health. Applications extend beyond contraception, with IUDs often prescribed to manage menstruation disorders like menorrhagia. The primary end-users encompass women seeking effective birth control solutions across developed and developing regions. Market growth is driven by several factors including increased awareness about sexual health, government initiatives for population control, and improved healthcare infrastructure facilitating access. Opportunities abound in rural outreach programs where contraceptive use is traditionally lower and digital healthcare platforms that can provide consultations or make IUD information accessible. Technological advancements, such as IUDs with extended durations and additional health benefits like hormonal balance, also present promising avenues. However, limitations include misconceptions about side effects, cultural barriers in certain regions, and the initial cost of insertion which might deter certain demographics. Market challenges stem from potential complications like infections post-insertion and limited access in underdeveloped areas where healthcare systems are less robust. Innovative areas for research include developing cost-effective, biodegradable IUDs and smart devices that allow healthcare providers to monitor patient health remotely. Business growth can be driven by enhancing partnerships with healthcare agencies to promote education and awareness programs. The IUD market oscillates between high innovation and cultural hesitancy, with a significant opportunity lying in demystifying misunderstood aspects of IUDs and integrating them into broader healthcare plans. A keen focus on personalized medicine and biotech advancements could redefine the product offerings, meeting diverse consumer needs and fostering significant market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 4.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intrauterine Devices Market

The Intrauterine Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption to avoid unintended pregnancies
    • Government and NGO initiatives to promote IUD
  • Market Restraints
    • Concerns related to lost strings and risk of infection due to IUD usage
  • Market Opportunities
    • Focus on the design of next-generation IUD (intrauterine device)
    • Emergence of smart intrauterine contraceptive device
  • Market Challenges
    • Limited awareness and adoption among population

Porter's Five Forces: A Strategic Tool for Navigating the Intrauterine Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intrauterine Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intrauterine Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intrauterine Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intrauterine Devices Market

A detailed market share analysis in the Intrauterine Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intrauterine Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intrauterine Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intrauterine Devices Market

A strategic analysis of the Intrauterine Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDIKAL SAN. TIC. LTD. STI., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.

Market Segmentation & Coverage

This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Hormonal: Progestogen-releasing IUD and Nonhormonal: Copper-containing IUD.
  • Based on Age Group, market is studied across 15-24 Years, 25-34 Years, 35-44 Years, and Above 44 Years.
  • Based on End User, market is studied across Clinics, Community Health Care Centres, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption to avoid unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote IUD
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
      • 5.1.3.2. Emergence of smart intrauterine contraceptive device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and adoption among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intrauterine Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Hormonal: Progestogen-releasing IUD
  • 6.3. Nonhormonal: Copper-containing IUD

7. Intrauterine Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24 Years
  • 7.3. 25-34 Years
  • 7.4. 35-44 Years
  • 7.5. Above 44 Years

8. Intrauterine Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Health Care Centres
  • 8.4. Hospitals

9. Americas Intrauterine Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intrauterine Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intrauterine Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
  • 2. Agile Therapeutics, Inc.
  • 3. Allergan Plc by Abbvie Inc
  • 4. Ava AG
  • 5. Bayer AG
  • 6. Cardinal Health, Inc.
  • 7. Contrel Europe NV
  • 8. CooperSurgical Inc.
  • 9. Egemen International
  • 10. ERENLER MEDIKAL SAN. TIC. LTD. STI.
  • 11. Eurogine S.L.
  • 12. Fuji Latex Co., Ltd.
  • 13. HLL Lifecare Limited
  • 14. HRA Pharma, SAS
  • 15. Melbea AG
  • 16. Merck & Co., Inc.
  • 17. Meril Life Sciences Pvt. Ltd.
  • 18. Mona Lisa N.V.
  • 19. Mylan NV by Viatris Inc.
  • 20. Novartis AG
  • 21. Ocon Medical Ltd
  • 22. Pregna International Limited
  • 23. Prosan International BV
  • 24. Searchlight Pharma Inc.
  • 25. SMB Corporation of India

LIST OF FIGURES

  • FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY 35-44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY ABOVE 44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY COMMUNITY HEALTH CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023